Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (Alliance) N9831 Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Proto-Oncogene Proteins c-myc
  • Receptor, ErbB-2

abstract

  • Our data do not support an impact of tumor MYC protein expression on differential benefit from adjuvant trastuzumab.

publication date

  • October 15, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3805021

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-13-0558

PubMed ID

  • 23965903

Additional Document Info

start page

  • 5798

end page

  • 807

volume

  • 19

number

  • 20